美股市场个股详情
BIIB 渤健公司
- 195.150
- -1.650-0.84%
收盘价 04/16 16:00 (美东)
- 195.650
- +0.500+0.26%
盘后 17:54 (美东)
283.67亿总市值24.49市盈率TTM
197.730最高价194.940最低价87.19万股成交量196.200今开196.800昨收1.71亿成交额0.60%换手率24.49市盈率(静)1.45亿总股本319.76052周最高1.92市净率282.60亿流通值194.94052周最低--股息TTM1.45亿流通股480.180历史最高--股息率TTM1.42%振幅2.625历史最低196.100平均价1股每手
关于渤健公司公司
生物基因公司是一家生物制药公司，从事神经和神经退行性疾病的发现、开发和提供治疗。其产品包括治疗多发性硬化症的TECFIDERA、VUMERITY、AVONEX、PLEGRIDY、TYSABRI和FAMPYRA，治疗SMA的SPINRAZA，治疗阿尔茨海默病的ADUHELM和治疗严重斑块性银屑病的FUMADERM。
公司介绍
公司代码BIIB
公司名称渤健公司
上市日期1991/09/17
发行价格15.00
成立日期1978
CEOMr. Christopher A. Viehbacher
所属市场纳斯达克
员工数量7570
证券类型海外普通股
年结日12-31
公司地址225 Binney Street
城市Cambridge
省份马萨诸塞州
国家美国
邮编02142
电话1-617-679-2000
董事高管
- 姓名
- 职务
- 年薪
- Christopher A. Viehbacher
- Director, President and Chief Executive Officer
- 3048.86万
- Michael R. Mcdonnell
- Executive Vice President and Chief Financial Officer
- 720.98万
- Susan H. Alexander
- Executive Vice President and Chief Legal Officer
- 679.02万
- Robin C. Kramer
- Senior Vice President and Chief Accounting Officer
- --
- Dr. Ginger Gregory, PhD
- Executive Vice President and Chief Human Resources Officer
- 508.03万
- Rachid Izzar
- Executive Vice President, Global Product Strategy and Commercialization
- --
- Nicole Murphy
- Executive Vice President, Pharmaceutical Operations and Technology
- 492.97万
- Adam Keeney, PhD
- Executive Vice President, Head of Corporate Development
- --
- Dr. Jane Grogan, PhD
- Executive Vice President, Head of Research
- --
- Dr. Priya Singhal, M.D.,M.P.H.
- Executive Vice President and Head of Development
- --
- Caroline D. Dorsa
- Chairman of the Board
- 42.54万
- Monish D. Patolawala
- Director
- --
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 41.04万
- William A. Hawkins, III
- Independent Director
- 41.04万
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 46.04万
- Dr. Maria C. Freire, PhD
- Independent Director
- 35.16万
- Jesus B. Mantas
- Independent Director
- 41.04万
- Susan Langer
- Independent Director
- --
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
